Nailfold capillary density is importantly associated over time with muscle and skin disease activity in juvenile dermatomyositis
- PMID: 21156669
- DOI: 10.1093/rheumatology/keq407
Nailfold capillary density is importantly associated over time with muscle and skin disease activity in juvenile dermatomyositis
Abstract
Objectives: To investigate the longitudinal association of nailfold capillary density (NCD; as a potential marker of activity) with various other clinical measures of disease activity and to evaluate baseline NCD as a predictor of disease outcome in children with JDM.
Methods: Data from 809 clinic visits from 92 JDM patients were prospectively collected at each clinic visit over a time period of 5.5 years. The number of capillaries per millimetre at the distal nailfold was scored using a stereomicroscope. Disease activity was determined using the Childhood Myositis Assessment Scale (CMAS) and a modification of the validated disease activity score (DAS), which included three skin (SDAS) and three muscle (MDAS) criteria. An inception cohort subgroup (n=28) with a baseline visit at diagnosis was analysed separately.
Results: Both DAS subscores, MDAS (β = -0.04437, P < 0.0001) and SDAS (β = -0.1589, P < 0.0001), as well as the CMAS (β = 0.02165, P < 0.0001) were significantly associated with loss of end row nailfold capillary over time (multiple regression mixed-model analysis). All patients in the inception subcohort showed a reduced baseline NCD (diagnostic sensitivity = 100%) that improved as the disease improved, but this did not predict longer term outcome or course of disease.
Conclusion: NCD is a marker of skin and muscle disease activity, and is an important measure of disease activity changes from visit to visit. Determination of capillary density may be useful when making treatment decisions. A decrease in NCD may be considered for inclusion in the diagnostic criteria due to its high sensitivity.
Similar articles
-
Skin involvement in juvenile dermatomyositis is associated with loss of end row nailfold capillary loops.J Rheumatol. 2004 Aug;31(8):1644-9. J Rheumatol. 2004. PMID: 15290747
-
Nailfold capillary microscopy in adults with inflammatory myopathy.Semin Arthritis Rheum. 2010 Apr;39(5):398-404. doi: 10.1016/j.semarthrit.2008.09.003. Epub 2008 Nov 20. Semin Arthritis Rheum. 2010. PMID: 19022479
-
Oropharyngeal dysphagia in juvenile dermatomyositis (JDM): an evaluation of videofluoroscopy swallow study (VFSS) changes in relation to clinical symptoms and objective muscle scores.Rheumatology (Oxford). 2007 Aug;46(8):1363-6. doi: 10.1093/rheumatology/kem131. Epub 2007 Jun 14. Rheumatology (Oxford). 2007. PMID: 17569746
-
Juvenile dermatomyositis: extramuscular manifestations and their management.Curr Opin Rheumatol. 2009 Nov;21(6):575-80. doi: 10.1097/BOR.0b013e328331927e. Curr Opin Rheumatol. 2009. PMID: 19730375 Review.
-
Clinical assessment in juvenile dermatomyositis.Autoimmunity. 2006 May;39(3):197-203. doi: 10.1080/08916930600622553. Autoimmunity. 2006. PMID: 16769653 Review.
Cited by
-
Juvenile dermatomyositis: association between nail fold capillary end row loop- area under the curve- and disease damage indicators.Pediatr Rheumatol Online J. 2023 Nov 13;21(1):137. doi: 10.1186/s12969-023-00919-3. Pediatr Rheumatol Online J. 2023. PMID: 37957619 Free PMC article.
-
Juvenile Dermatomyositis: Association between Nail Fold Capillary End Row Loops Area Under the Curve and Disease Damage Indicators.Res Sq [Preprint]. 2023 Aug 21:rs.3.rs-3235841. doi: 10.21203/rs.3.rs-3235841/v1. Res Sq. 2023. PMID: 37674726 Free PMC article. Updated. Preprint.
-
B Cell Lymphocytosis in Juvenile Dermatomyositis.Diagnostics (Basel). 2023 Aug 8;13(16):2626. doi: 10.3390/diagnostics13162626. Diagnostics (Basel). 2023. PMID: 37627885 Free PMC article.
-
Deep learning and computer vision techniques for microcirculation analysis: A review.Patterns (N Y). 2022 Dec 1;4(1):100641. doi: 10.1016/j.patter.2022.100641. eCollection 2023 Jan 13. Patterns (N Y). 2022. PMID: 36699745 Free PMC article. Review.
-
Review of an Anti-CD20 Monoclonal Antibody for the Treatment of Autoimmune Diseases of the Skin.Am J Clin Dermatol. 2023 Mar;24(2):247-273. doi: 10.1007/s40257-022-00751-7. Epub 2023 Jan 11. Am J Clin Dermatol. 2023. PMID: 36630066 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
